Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
-
661
Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR.
Published 2024“…There was a significant decrease in the ratio of pmTOR to mTOR. …”
-
662
Immunoblotting for JAK, STAT, and SMAD.
Published 2024“…There was also a significant decrease in SMAD and pSMAD in the SIT group. …”
-
663
-
664
-
665
-
666
Immunoblotting for insulin sensitivity markers.
Published 2024“…There was also a significant decrease in pPKC alpha in the SIT-I myocardium compared to SIT-N. …”
-
667
-
668
-
669
-
670
Blocking of MC1R, MC2R or MC5R causes a decrease in the enucleation ratio of erythrocytes.
Published 2015“…The enucleation ratio was decreased in the erythroblasts treated with anti-MC1R nAb, anti-MC2R nAb or anti-MC5R nAb. *, <i>P <</i> 0.0001, each point versus control. n = 3; error bars, s.e.m. …”
-
671
rVλ6Wil fibrils cause a decrease in cardiomyocytes MTT reduction without inducing cell death.
Published 2015“…(C) Cell number, quantified using crystal violet (black) did not decrease over 72 h of incubation with 1 μM rVλ6Wil fibrils despite a decrease in MMT reduction (grey; n = 3 samples per time point). …”
-
672
-
673
VGB treatment decreased the number of GFAP positive cells in hippocampus of <i>Tsc1</i><sup>GFAP</sup>CKO mice.
Published 2013“…(B) Quantitative analysis demonstrated a 2–2.5 fold increase in GFAP-positive cell in vehicle-treated <i>Tsc1</i><sup>GFAP</sup>CKO group (KO + Veh) compared with vehicle-treated control group (Cont + Veh) in neocortex (CT), dentate gyrus (DG) and CA1 of hippocampus. …”
-
674
Wounds treated with sDll4-Fc have increased vascular density but decreased vascular maturation in direct proportion to the dosage level.
Published 2012“…B) Vascular smooth muscle cell coverage is decreased about 3-fold in relation to PBS-injected control mice throughout the experimental days in both tested groups. …”
-
675
-
676
-
677
-
678
-
679
-
680